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The virus plaque assay has been developed as a tool for enumerating activated 
lymphocytes. In previous studies using mitogens it was found that the assay detects 
activated T- but not activated B-lymphocytes. In the present studies, the mixed lym- 
phocyte reaction was studied by the virus plaque assay as well as by incorporation of 
thymidine and development of cytotoxic lymphocytes. In combinations differing at the 
entire major histocompatibility complex, approximately 1% of the cells were activated 
and treatment with anti-thy.1 serum totally abrogated the virus plaque forming cell 
(V-PFC) response. In studies on the A.TH-A.TL recombinants and the AQR-BlO/ 
6R recombinant strains, incompatibility at the H-2-K or H-2-D loci were found not 
to be capable of activating T-cells to produce virus plaques. In contrast, differences 
in I or I plus S regions caused a marked T-cell activation, 3-6s of the cells being 
V-PFC. There was a general parallelism between thymidine incorporation and the 
V-PFC, and it was not possible to dissociate the cell types carrying out each of these 
functions by kinetic studies. However, preinfection of responding cells with the virus 
used in these studies, vesicular stomatitis virus, caused a complete abrogation of thy- 
midine incorporation, indicating that the activation of virus is an earler stage than 
DNA synthesis, and that viral activation will block further ccl1 replicaton and is 
probably a lytic event. 
INTRODUCTION 
The mixed lymphocyte and graft-versus-host reactions are unique among im- 
munologic reactions in that a very high response is obtained with unimmunized cells, 
which is apparently not increased after repeated immunization. The frequency of 
cells responding to foreign histocompatibility antigens has been estimated to be as 
high as l-376 (l-5). In addition, the mixed lymphocyte reaction (MLR) stimu- 
lates several parameters of allograft rejection ; blast cell transformation and thy- 
midine incorporation being regarded as a recognition phase and lymphocyte- 
mediated cytotoxicity serving as the effector phase. 
As recombinant mouse strain combinations became available, it has been possible 
to test the importance of different H-2 regions in MLR both for stimulation of the 
recognition function and as target determinants for cell-mediated cytolysis (6-9). 
1 Supported by grants from the National Institutes of Health and The Kational Foundation. 
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In these studies, it has been shown that I-region differences give strong MLC 
stimulation, whereas K or D region differences give very weak, if any, MLC 
stimulation. In contrast, however, K and D region differences serve as target 
determinants for destruction of cells bearing them by lymphocytes activated by 
stimulating cells differing at I region plus K or D loci. However, target cells from 
strains differing solely in I region genes either are not, or only poorly killed by 
lymphocytes responding solely to products of this region, 
A virus plaque assay has been developed for estimating the number of activated 
thymus-derived lymphocytes. It is based on the observation that unstimulated small 
lymphocytes do not support the replication of RNA viruses, whereas, antigen or 
mitogen stimulated lymphocytes acquire the capacity to do so (10-12). In previous 
studies of activation of mouse spleen cells by mitogens, it was found that con- 
canavalin A (Con A), phytohemagglutinin (PHA), and pokeweed mitogen were 
highly effective at stimulating virus plaque forming cells (12). As many as 6-10% 
of the spleen cells stimulated with Con A were capable of producing virus, and all 
of these were found to be T-cells since the response could be ablated by treatment 
with anti-thy.1 serum plus complement. In contrast, while lipopolysaccharide 
(LPS) was effective in stimulating thymidine incorporation, there was only a 
very slight increase above background of virus plaque forming cells, indicating that 
activated B-lymphocytes are probably not measured by this assay. In these studies, 
MLR between strains congenic at H-2 but differing at the M locus were studied. 
Killer cells were not seen in this system yet the virus plaque assay appeared not to 
detect cells activated in this system. Consequently, the present studies were under- 
taken to explore in greater detail the requirements for production of V-PFC in MLR 
by utilizing a variety of mouse H-2 recombinant strains. 
MATERIALS AND METHODS 
Mice. All of the experiments were done with sets of inbred and congenic resistant 
strains of mice. The H-2 haplotypes of the strains employed and the alleles at the 
regions of the H-2 complex are given in Table 1. 
TABLE 1 
THE H-2 HAPLOTYPE AND THE COMPOSITION OF H-2 REGIONS 
Strain Abbreviation H-2 haplotype H-2 regions 


























k k kd 
s k kd 
s s sd 
s s ss 
q k kd 
q d 
: ;: dd 
k k db 
k k/b b b 
b b bb 
d d dd 
b b bb 
b? b? b b 
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A.TL carries the H-2t1( H-2t1) haplotype,5 derived from recombination between 
H-2”‘( H-2”‘) ( t s rain A.AL) and H-2” (strain A.SW) (14). A.TH carries the 
the H-2t2(H-2t11) haplotype, derived from recombination between H-2” (strain A) 
and H-2” (strain A.SW) (15). A.TL and A.TH are identical at H-2K and H-2I> 
loci, but different at Ir-lA, Ir-lB, and Ss-Slp loci. 
AQR carries the H-2s1 H-2r-K1J) haplotype, derived from recombination between 
H-2q(strain T138) and H-2”( strain Bl0.A). Although AQR is not congenic with 
BlO, it had undergone a total of four backcrossings to BlO before the line was 
established by intercrossing and thus carries a considerable portion of the HI0 
genome ( 16). B 1O.T (6R) carries the H-2@ ( I-I-2yms”) haplotype derived from 
recombination between H-2”( strain B1O.A) and H-2q(strain Bl0.G) (17). 
211 and 4R were derived from recombination between H-2*(strain Bl0.A) and 
H-2b(strain BlO), are indistinguishable from one another at H-2K and H-2D loci 
( 16) and differ at Ir-1B locus and by Slp antigen. Skin graft exchanges between 
them are accepted for at least 40 days. 
H(z1) is an H-2 mutant, originally detected in a (C57BL/6 X BALB/c) I;1 
hybrid and crossed onto the C57BL/6 background (IS). The mutation occurred in 
the H-2 complex to the left of Ss-Slp locus, probably in the K region. Extensive 
immunization failed to produce cytotoxic or hemagglutinating antisera between 
H( zl) and I36 until recently (19). Skin grafts were rejected rapidly. 
Mixed ipzphoq~tc cztltzrre. Mouse spleen cells were usecl as both responding and 
stimulating cells. Stimulating cells were treated with mitomycin C (25 yg/ml, 37°C 
for 20 min) and washed three times. Five million responding cells were cultured 
with 5 X 10G mitomycin C-treated syngeneic or allogeneic stimulating cells in 2 ml 
vol of RPnI 1640 (Associated Biomedic Systems, Inc., Buffalo, N.Y.), supple- 
mented with heat-inactivated (56°C for 30 min) fetal calf serum (Reheis Chemical 
Co., Chicago, Ill., Lot No. H72208), 5 ml/100 ml ; penicillin, 100 units/ml ; strep- 
tomycin, 100 pg/ml; and L-glutamine, 2 m!U (RPNI 1640, 5% FCS), in Linbro 
culture dishes (Linbro Chemical Co., New Haven, Corm., FB-lG-24-TC, lh-mm 
diam), at 37°C in an atmosphere of 5% CO:! in humidified air. 
On the fourth day, cells from three or four replicate cultures were collectetl, 
centrifuged once, resuspended in fresh culture medium and assayed for (3H 1 thy- 
midine incorporation and virus replication. 
Assay of t3H] thgmidine incorporation. Two-tenths milliliter of cell suspension 
recovered from mixed lymphocyte cultures was transferred to microculture plate 
(IS-FB-96OTC, Linbro Chemical Co., T\‘ew Haven, Corm.) and incubated with 2 
PCi of [“t-I] thymidine (sp act 2.0 Ci/mmole, New England Nuclear, Boston, 
Mass.) for 6 hr at 37°C in 5% CO, in humidified air, Triplicate or quatlruplicate 
cultures were made for each combination. The ctdtures were harvested onto glass- 
fiber filters, washed with saline, precipitated with 5% TCA, and washed with 
methanol, 1)~ using a semiautomatic multiple sample har\.ester (NASH-IT, Nicro- 
biological .2ssociates, Bethesda, Md). The glass fiber filters with precipitates were 
placed in LSC Mini-Vials (Xew England Nuclear, Boston, Jlass.) , dried, dissolved 
in 4.5 ml of Omnifluor (New England Nuclear, Boston, Mass.) in toluene (4 
g/liter), and assayed by liquid scintillation spectrophotometry. 
5 Proposed genetic nomenclature for the H-2 complex and designation of H-2 haplotypcs 
(6, 13) are used in the paper (old symbols are sho\vn in parentheses.) 
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Y&U, plaque assay. Details of the method have been described previously (lO- 
12). After viable cell counting by trypan blue exclusion, 1 x lo6 viable lymphocytes 
were transferred to 12 X 75-mm a Falcon plastic tube, washed once, and resus- 
pended in 0.2 ml of culture medium. The cells were infected with vesicular stomatitis 
virus (VSV) at a multiplicity of 50 and incubated at 37°C in 5% CO:! in air for 
2 hr to permit virus adsorption and penetration. The excess virus was then removed 
by washing once, and free virus remaining was neutralized with 0.02 ml of inacti- 
vated guinea pig anti-VSV serum by incubation for 1 hr at 4°C. The cells were 
washed three times more and resuspended in 2 ml of Eagle’s MEM with 6% 
fetal calf serum. A 0.2-ml aliquot of VSV-infected cell suspensions was mixed with 
1 ml of 1% agar in MEM-6% FCS and plated on L-cell monolayer in 60-mm 
Falcon culture dishes. When this layer af agar had solidified, a second 1.5-ml 
agar layer was added as a nutrient layer. Each cell sample was plated in three log 
dilutions, and each dilution was plated in duplicate. At the end of plating, cell counts 
were made in 0.2% trypan blue to determine the number of viable cells actually 
plated, The plates were incubated at 37°C in 5% COZ in air for 2 days, then vitally 
stained with neutral red solution (1: 10,000 in phosphate-buffered saline), and the 
virus plaques were counted. The results were expressed as V-PFC (virus plaque 
forming cells)/106 cells actually plated or corrected as V-PFC/lOs cells cultured. 
Assay of lymphocyte cytotoxicity. P-815 mastocytoma cells (DBA/2, H-2d), 
and EL-4 lymphoma cells (C57BL/6, H-2b) were used as target cells. They were 
maintained in Joklik modified MEM spinner medium with 5% fetal calf serum in 
stationary culture. Target cells (5 X lo6 cells/ml) were labeled with 100 &i of 
Naa51Cr04 (New England Nuclear, Boston, Mass.) at 37°C in 5% COP in air 
for 45 min. After three washings they were adjusted to 1 X lo6 viable cells/ml 
in RPM1 1640-5%FCS. 
The cytotoxicity assay was a modification of that described by Cerottini and 
Brunner (20). Lymphocytes from mixed lymphocyte cultures were adjusted to a 
concentration of 5 x lo6 viable cells/ml in RPM1 1640-5% FCS. One-half milli- 
liter of lymphocyte suspension (2.5 x 106) and 0.05 ml of target cell suspension 
( 5 x lo*) were incubated in 12 x 75-mm Falcon plastic tubes (lymphocyte: target 
cell ratio = 50: 1) at 37°C in 5% CO2 in air for 5 hr without rocking. 
At the end of the incubation period, 1 ml of RPM1 1640-5s FCS was added 
to each tube. The cells were mixed well and centrifuged. One milliliter of the super- 
natant fluid was aspirated and the amount of radioactivity released in the super- 
natant fluid was determined. Maximum 51Cr release was determined by counting the 
amount of 51Cr released into supernatant fluid by freezing and thawing 5 X lo4 
target cells three times. Spontaneous 51Cr release was determined as an amount of 
51Cr released into supernatant fluid by incubating 5 X lo4 target cells in culture 
medium alone. The results were expressed as a percentage of lysis using the follow- 
ing formula : 
Experimental release - spontaneous release 
maximum - spontaneous release 
x loo. 
All assays were done in triplicate. 
Anti-thy-l.2 treatment. AKR anti-CBA thymocyte serum was a gift from Dr. M. 
Howe. Rabbit serum absorbed with EL-4 cells in the presence of EDTA was used 
as the source of complement (RS) (21). Anti-thy-l.2 treatment was done accord- 
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ing to the method of E. A. Boyse (21). RPM1 1640 with 2% FCS was used as 
suspending and diluting medium. Mixtures of equal volumes of (1) anti-thy-l.2 
serum (1: 20) ; or normal mouse serum (1: 20) ; (2) KS (1: 3) ; and (3) lympho- 
cytes from mixed lymphocyte culture (5 x 10F/ml) was incubated at 37°C in a 
water bath for 45 min. After incubation, viable cell counts were made hy adding 
0.1 ml of 0.2% trypan blue solution to 0.15 ml of incubation mixture. 
Percentage of specific kill by anti-thy-l .2 serum was clrtt~rniinetl a5 follows : 
Numhcr of viahlc cells with normal m~~ise serum - 
number of viable cells with anti-Thy-l.2 serum 
x 100. 
numhcr of viable cells with normal ~IOLIW serum 
RESUTzTS 
An increase in the number of cells which support the replication of an RXA 
virus, vesicular stomatitis virus (VW), was found in the mixed lymphocyte 
culture using combinations of congenic resistant strains, BlO and BlO.D2 (Table 2). 
The virus plaque forming cell (V-PFC) response in the mitogen-activated mouse 
spleen cell cultures was previously shown to be predominantly, and probably 
exclusively, a T-cell response (12). In order to ascertain whether the virus plaque 
assay also detects activated T-lymphocytes in the RILC, the cells harvested from 
the MLC on day 4 (5 X 106/m1) were treated with AKK anti-thy-l.2 serum ( 1: 20) 
and absorbed rabbit complement (1 :3). Then 1 X lo0 cells which survived the 
treatment were infected with VSV for the virus plaque assay. Anti-thy-l.2 treat- 
ment lysed 49% of BlO spleen cells stimulated with BlO.D2 spleen cells, and 35% 
of BlO spleen cells cultured with syngeneic spleen cells. The V-PFC response was 
expressed as V-PFC/lOB cells treated. Anti-thy-l.2 treatment reduced V-PFC in 
stimulated cultures by 9370 to the unstimulated background level (Table 2). Similar 
reductions were observed in [ 3H] thymidine incorporation. These results confirm 
TABLE 2 
EFFECT OF ANTI-THY-l.2 SERUM ON \‘-PFC IN hILCcL 
Culture Cell recovery 
from culture 
(5 1 
Treatment Specilic kill V-PFC/lOG 
by anti- cells treated 
thy-l.2 
cc;) 
B10 + BlO,,, 20 
I310 + BlKDL,,, 42 
EMS + c 
;\nti-thy-l.2 + C 
SMS + c 





a BlO spleen cells, 5 X 106, were cultured with 5 X 10” mitomycin C-treated BlO or BlO.DL 
spleen cells in RPM1 1640 + 57, FCS for 4 days. Viable spleen cells, 10 X lob, from pooled 
cultures were treated with anti-thy-l.2 or normal mouse serum (1:60, final dilution) and absorbed 
rabbit complement (1:9, final dilution). Surviving lymphocytes, 1 X 106, were then infected with 
\‘SV for the virus plaque assay. VPA was done in duplicate. The results were corrected as V-PFC/ 
lo6 cells treated with anti-thy-l.2 serum. 
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TABLE 3 
RELATIVE IMPORTANCE OF DIFFERENT H-2 REGIONS FOR V-PFC RESPONSE’ 
Responding Stimulating H-2 region Virus plaque assay C3H]thymidine 
cells cells difference (V-PFC/lOB incorporation 
cells plated) b (cpm/culture)c 
A.TH A.TH None 1,355 xk 292 6,281 f 62 
A.TH A.TL I, s 22,064 f 3,287 56,726 f 598 
A.TH A.SW D 1,254 f 109 4,866 f 78 
A.TH A.AL K, I, S 13,398 f 2,349 46,675 f 1,144 
A.TL A.TL None 2,212 f 146 6,939 f 142 
A.TL A.TH I, s 28,640 f 1,646 32,787 zt 1,542 
A.TL A.AL K 1,793 f 182 7,119 f 319 
A.TL A.SW I, S, D 11,787 f 227 19,773 l 1,212 
a Spleen cells, 5 X 108, were cultured with 5 X lo6 mitomycin C-treated stimulating spleen cells 
in 2 ml of RPM1 1640 with 5% FCS for 4 days. Viable cells, 1 X 106, from pooled cultures were 
infected with VSV for the virus plaque assay. Two-tenths-milliliter aliquots of culture were in- 
cubated with 2 rCi of C3H]thymidine for 6 hr. 
b Mean f SE (n = 3). 
c Mean f SE (n = 4). 
that the MLC reaction is predominantly T-cell response and activated T-lympho- 
cytes can be enumerated by the virus plaque assay. 
2. Reladve Importance of Different Regions of the H-2 Complex for V-PFC 
Response 
MLC and the cell-mediated lympholysis (CML) have been regarded as in vitro 
correlates of the recognition phase and effector phase of the allograft reactions, 
respectively. Recent studies using recombinant strains within H-Z complex enhanced 
our knowledge about relative importance of different regions of the H-2 complex 
for MLC stimulation (7, 8) and generation of the cytotoxic lymphocytes (9). 
As a means to clarify whether the virus plaques assay measures all the activated 
T-lymphocytes or a subpopulation of the activated lymphocytes such as effector 
cells, the relative importance of different regions of the H-2 complex for the V-PFC 
response was studied using sets of recombinant strain combinations. 
A representative result of the most informative strain combinations is shown 
in Table 3. A.TH and A.TL strains, which are identical at H-2K and H-2D loci, 
but differ in I and S regions, stimulate strong V-PFC response reciprocally. On 
the other hand, A.TH spleen cells cultured with A.SW spleen cells (H-2D locus 
difference), or A.TL spleen cells cultured with A.AL spleen cells (H-2K locus 
difference) did not give significant V-PFC response above their control syngeneic 
cultures. Addition of K or D region differences to the I and S region difference did 
not increase the V-PFC response (Table 3). 
The importance of the region between H-2K and H-2D for V-PFC response was 
also demonstrated in another recombinant strain. AQR spleen cells stimulated with 
6R cells, which are identical at H-2K and H-2D loci but different in I and S 
regions, also gave strong V-PFC responses. The same AQR spleen cells cultured 
with BIO.A cells which are different at H-2K locus gave no significant V-PFC 
response (Table 4). 
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RELATIVE IMPORTANCE OF DIFFERENT H-2 REGIONS FORV-PFC KESPOKSE" 
Responding Stimulating H-2 region \.irus plaque assay rTH]thymidine 
CCIIS cells difference (V-PFC/lOG incorporation 
cells plated) b (cpnl/cultrlreJc 
AQR AQR None 1,302 z!z 145 2,610 -f 165 
AQK 6R I, s 10,797 & 2,251 9,443 f 916 
AQK B1O.A K 1,359 f l-16 3,835 i Si 
“,D,c See footnotes u, b, c, Table 3. 
Strains 4R and 2R derived from recombinations of H-2” and H-2” chromosome 
and are identical at H-2K, H-2D, and I-A loci. 4R spleen cells stimulated with 2R 
cells showed a significant but relatively weak V-PFC response. Addition of 1) 
region incompatibility (4R stimulated with BIO.A) increased the magnitude of the 
V-PFC response. The K and I-A region incompatible combination (4R stimulated 
with RlO) gave higher V-PFC response than I-B, S, and D region incompatible 
combination (4R stimulated with BIO.A) (Table 5). 
H( zl) is congenic with B6, the only known difference being a mutation in the 
H-2 complex, to the left of Ss-Slp locus, presumably in K. The exact location and 
extent of the mutation is not clear. B6 and H( zl ) stimulated reciprocally to give 
a marked lT-PFC response (Table 6). 
3. Kinetics of tlzc V-PFC Response in MLC 
As another approach to clarify the relationship of the V-PFC response with cell 
proliferation and development of cytotoxic lymphocytes, their kinetics were com- 
pared in the mixed lymphocyte culture. BlO spleen cells cultured with BlO.DZ 
spleen cells or BlO cells were harvested each day and assayed for virus replication, 
[3H]thymidine incorporation and cytotoxicity against P-815 mastocytoma (IT-2”) 
target cells (Fig. 1). The increment of V-PFC or counts per minute in allogeneic 
culture above syngeneic culture increased apparently exponentially till day 5 and 
then declined sharply. The ratio of counts per minute in allogeneic cultures to 
counts per minute in syngeneic culture reached its peak on clay 4 and declined 
thereafter mainly because of increased background [“H] tl iymitline incorporation in 
TABLE .5 
I<ELATIVE IMPORTANCE OF DIFFERENT H-2 Kt<c.roxs FOR \‘-PFC KLF,PONW~ 
~~ 
Responding Stimulating H-2 region \Yrus plaque assay C”H]thymidine 
cells cells difference (V-PFC/lOc incorporation 
cells plated)b (rpm/culture)~ 
4R 4R None 1,791 f 11 3,319 f 85 
4R 2R I-B, S 6,175 Y!Z 328 10,655 f 464 
41~ B1O.A I-B, S, I) 12,937 f 1,910 22,400 zt 517 
41-t I310 K, I-:\ 39,584 f 7,179 38,377 rt 1,283 
___ ~.._ --~- .--- ~~ ~~ 
o,*,c See foot notes a, b, c, Table 3. 
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TABLE 6 
RELATIVE IMPORTANCE OF DIFFERENT H-2 REGIONS FOR V-PFC RESPONSE” 
Responding Stimulating H-2 region 
cells cells difference 
B6 B6 None 
B6 H (~1) Mutation in K or I 
B6 BlO.D2 K, I, S, D non-H-2 
H (21) HW) None 
H(z1) B6 Mutation in K or I 
H(zl) BlO.D2 K, I, S, D non-H-2 
a,b*c See footnotes a, b, c, Table 3. 
Virus plaque assay C3H]thymidine 
(V-PFC/lOs incorporation 
cells plated) b (cpm/cuIture)” 
2,194 f 337 3,998 f 121 
20,745 f 2,497 44,124 f 1,409 
74,465 f 4,259 43,496 f 1,730 
13,781 f 4,526 20,501 f 1,363 
66,707 f 6,859 44,669 f 2,120 
70,501 f 11,982 52,948 f 3,400 
syngeneic culture. Lymphocyte cytotoxicity was very weak on days 2 and 3, rose 
on day 4, reached its peak on day 5 and remained high. Changes in culture condi- 
tions (data not shown) had a significant effect on the kinetics, and the results 
indicated that the kinetics of all three reactions were similar and not a useful 
parameter for distinguishing subpopulations. 
4. Efect of Preinfection with VSV on [3H] Thymidine Incorporation in the A4ixed 
Lymphocyte Culture 
In order to distinguish whether the virus replicating cells and the thymidine 
incorporating cells are the same cells or distinct cell populations, the effect of 
preinfection of spleen cells with VSV on [SH]thymidine incorporation was investi- 
gated. The basis of this experiment is that, if virus replication occurs in the same 
cells as [3H] thymidine incorporating cells, virus replication would be likely to 
FIG. 1. BlO spleen cells (5 X 10’) were cultured with 5 X 10” mitomycin C-treated BlO.Dz 
or BlO spleen cells. V-PFC/lO” viable cells plated (means of triplicate assays) : (0- --0), 
Increase in V-PFC in BlO + BlO.DZ, culture above BlO + BlO, culture. (A---- A), 
Increase in [‘Hlthymidine incorporation in B10 + BlO.DZ in culture above B10 f BlO, culture. 
(+----- l ) Increase in “Cr release from P-815 mastocytoma cells by cells from BlO- + 
BlO.DZ, culture above BlO + BlO, culture. 
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occur earlier after activation than DNA synthesis and virus infection may abolish 
[3H] thymidine incorporation. If [3H] thymidine incorporating cells are a distinct 
cell population independent of the virus replicating cells, virus infection will not 
affect [3H]thymidine incorporation in the mixed lymphocyte culture. B10 spleen 
cells were infected with VSV at a multiplicity of infection of 50 for 2 hr at 37°C 
and then washed three times to remove free virus. Infected El0 spleen cells and 
uninfected control B10 spleen cells were cultured with mitomycin C treated I<lO.D? 
or B10 spleen cells for 4 days and assayed for [3H] thymidine incorporation. 
The results of one such experiment is shown in Table 7. Preinfection with \-SV 
reduced [“HI thymidine incorporation both in allogeneic combination and in 
syngeneic combination. Although the allogeneic cultures of preinfected spleen cells 
usually gave higher [ 3H] thymidine incorporation than syngeneic cultures, the 
reduction in response by preinfection in terms of 4 cpm per culture \vas greater 
than 98%. 
DISCUSSIOS 
‘IVhen the virus plaque assay (VPA) was applied to MLR involving differences 
across the entire major histocompatibility complex, a striking increase in virus 
plaque forming cells was observed, indicating approximately 1% of the cells were 
activated (Table 2). Treatment of the responding cells with anti-thy. 1 serunl and 
complement totally abrogated the response demonstrating that the cells being 
detected by the virus plaque assay are indeed T-cells. 
Studies on two recombinant strain combinations indicated that stimulation of the 
V-PFC response by H-2” or H-2d locus incompatibility was insignificant (Tables 
3 and 4). However, I region or I + S region differences led to marked stimulation 
(3-6s V-PFC). Addition of H-2” or H-2” locus incompatibilities to I and S region 
differences did not increase the number of responding cells. 
Studies on the 4R and 2R recombinants indicated that significant stimulation 
was obtained in strains differing by I-A and I-B subregions, the former being 
essentially four times more effective than the latter. In this combination, there was 
some additive effect when a D end incompatibility was present together with 
differences at I-B and S. While this result might be suggestive of additional weak 
‘I’AB1.E 7 
EFFECT OF PREINFECTION WITH \'S\J ON [~H]THWIDINIX INCORPORATION IN ti1L.C~ 
I’reinfection Culture Counts per minu tc 
with VSV per culture* 
C-1 BlO.D2 + BlO.D2,, 4,515 * 147 
t-1 BlO.D2 + BlO,,, 20,177 + 223 A = 15,662 S.I. = 4.5 
C-t) BlO.D2 + BlO.D2, 56f 15 
(+I BlO.D2 + BlO, 170 f 39 A= 114 S.I. = 3.0 
a BlO.D2 spleen cells were incubated with VSV at m.o.i. of 100 at 37’C for 2 hr, then washed 
three times. Infected spleen cells (5 X 10”) were cultured with 5 X lo6 mitomycin C-treated 
BlO.D2 or BlO spleen cells for 5 days. Two-tenth-milliliter aliquots or cultures were labeled with 
2 pCi of [3H]thymidine for 6 hr. 
* Alean f SE (n = 4). 
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MLC determinants coded for by a region between SS and D, because additive 
effects of D or K end determinants in two other systems were not seen, the result 
could as well be an idiosyncrasy of the .2R-4R combination. 
One anomalous strain combination was studied, namely the B6/Hzl combination, 
which is believed to be identical to the I, S, and D regions, but to differ from the 
parent B6 strain by virtue of a mutation in the K region. Recently a serological 
difference has been detected between these strains ( 19). In the present studies, a 
strong activation of T-cells was detected by the VPA, which is consistent with the 
in viva finding that grafts between these strains are mutually rejected. It thus 
appears that in terms of genetic determinants governing lymphocyte activation, 
there were no significant differences between those stimulating thymidine incorpora- 
tion and those generating V-PFC. 
In order to try to distinguish the functional differences between activated lympho- 
cytes measured by thymidine incorporation, cytotoxicity, and the virus plaque assay, 
a series of kinetic experiments were carried out on the development of each of the 
functional parameters. Under conditions which optimized the yield of V-PFC and 
cytotoxic lymphocytes, the peak of all activities was found on day 5 of culture 
(Fig. l), although different culture conditions were found to have a significant 
effect on the peak responses of the various parameters. We are forced to conclude 
that it is very difficult to differentiate V-PFC either from thymidine incorporating 
cells or cytotoxic lymphocytes by means of kinetic studies. One additional difficulty 
in these studies on mouse lymphocyte cultures has been the variable and low per- 
centage of recovery of viable cells per culture, and it is not known whether there is 
any selectivity in cell loss for cells carrying out different functions under the differ- 
ent culture conditions. 
A comparison of the results with the virus plaque assay with other parameters 
used to study mixed lymphocyte cultures is given in Table 8. There appears to be 
a relative parallelism between the V-PFC response, thymidine incorporation, and 
graft rejection in z&o. The major discrepancy derives from the experiences in a 
number of laboratories which have been unable to demonstrate cell-mediated cyto- 
toxicity across determinants coded for solely by the I region. Unfortunately, it is 
difficult to interpret this observation, because Ia determinants coded for by the I 
region and detected serologically are usually not detected, or found in only low 
amounts, on mouse tumor cells and PHA activated blasts, the most common targets 
for cell-mediated cytolysis. There is some indication that since Ia is expressed in 
greater amounts on B-lymphocytes, killing across I region differences can be 
TABLE 8 
COMPAKISON OF V-PFC RESPONSE WITH MIXED LYMPHOCYTE REACTION, 
CELL-MEDIATED LYMPHOLYSIS AND GIUFT REJECTION 
Strain V-PFC 
combination response 
Mixed lympho- Cell mediated 
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tletectetl on LPS-stimulated blasts (22) ant1 in preliminary experinlents ii1 thi5 
lai~nratory, a tumor cell expressing serologically detected Ia determinants could h( 
killed by cells generated in an h,lLR between A.TH ant1 A.1’1,. Obviously, tllis 
point remains an important one to be clarified. 
&rhapS the InOSt LliieXpeCted filldillg iii theSe StLidieS WaS that illfeCti~Jl1 1, 
vesicular stomatitis virus was capable of abolishing lymphocyte actkation in the 
MIX. In the usual protocol, lymphocytes are acti\-atetl l)\- ;ZlLR, antigen, or mito- 
gen, ant1 then 3 or 5 days later infected with virus and plated for \--PfTC. TIN the 
experiments described in Table 7. resting lymphocytes were infected before laming 
stimulated in an RILR, ant1 the V-PFC and th\niidine incorporation wet-c mv;t- 
sured. Under these conditions in which V-EC are generated, there was an almost 
total ablation of tliymicline incorporation, and in preliminary studies in genrratiwl 
of killer ~~lll~~hOCyteS. It iS SLiggeSted fTOil1 theSe eXp-inKiltS, together With ~Jw\‘knlS 
experiments using mitotic inhibitors, that lymphocyte activation for replication of 
virus is an early event, and precedes UN,4 synthesis. These data are consistent 
with the results on synchronized human I\-m~~liol~lastoitl lines indicating that Tit-us 
replication occurs maximally during ( ;I of the cell cycle (25). Secondly, since 1-S\ 
is a lytic virus, activation of preinfected cells to produce virus most likelv leatls to 
destruction of the activated cells, and thus provides a lwtential strategy for elimiuat- 
ing histocompatibility antigen-reactive cells. Preliminary experiments carried ollt 
with Dr. Al. Sowakowski. T. Romano, ant1 J. Thorl~ecl~e (23, 2-F) indicate tll;lt 
1)reinfection of allogeneic spleen cells can ahgate their ability to generate q-aft- 
wrsus-host responses upon transfer to iiiimunologicall~ coml~roniisetl recilkits. 
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